FASLG and cancer: These exosomes activate the NF-κB, ERK, and c-FLIPL signaling pathways through the Fas/FasL-dependent trail, leading to MMP2, MMP9, and COX2 increased expression in B16 cancer cells, which play a critical role in cancer cell metastasis [72].